Certified by Founder Lodge
Slate Medicines
United States - Raleigh, NC
START UP
1 Disclosed Funding Rounds $130,000,000
0 Participating Investments
-
Founded date
2026
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Slate Medicines is a biotech company focused on advancing next generation therapeutics for migraine and other headache disorders. The Company’s lead program, SLTE-1009, is a potential best-in
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 25 ,2026 | Series A | $130,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Windmill(US) | $12,000,000 | (Apr 29, 2026)
TrialClinIQ | $150,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
